CHGCF
:US OTC

Add to watchlist
$32.32
Last updated:01/10/2022
CHGCF: US OTC
$32.32
Chugai Pharmaceutical Co. Ltd

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; r…

Dividend yield
1.72%
$0.5560 anually
P/E ratio
23.50x
vs. 20.20x forward
Payout ratio
40.44%
Yearly
CASH payout ratio
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
CHGCF dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company value
Market capitalization
Mega (53.12B)